Search

everythinglearnresearchcommunity

for

Search:↓

Four drugs were found that could potentially treat COVID-19 by inhibiting the virus in lab tests.

The study found that baicalin has different stable shapes in gas and water, with two shapes better for interacting with positive charges in water.

Some synthetic carbohydrate receptors, especially compounds 3 and 15, show strong potential for treating Zika virus.

Bupropion SR may help treat trichotillomania.

Baricitinib works better in adolescents than adults for treating severe alopecia areata.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Bupropion may help treat trichotillomania when fluoxetine doesn't work.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

Oncology specialists are disappointed by the discontinuation of the effective lymphoma treatment Bexxar.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

The research found a link between certain molecular features and the biological activity of BC3, which can help identify or create new active compounds.

Baricitinib helps regrow hair in teens with severe alopecia areata.

Hexahydrobenzo[f]quinolines are effective at blocking the enzyme 5α-reductase.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

Blocking GABA(A) receptors increases neuron sensitivity, showing GABA and glycine have different roles in pain.

Baricitinib is effective and safe for treating severe alopecia areata for up to 5 years.

Baricitinib improves quality of life and reduces anxiety and depression in severe alopecia areata patients with hair regrowth.

Propranolol, flunarizine, and divalproex sodium are equally effective for preventing migraines, but have different side effects.

Trichotillomania in dementia may be better treated with dopamine blockers like quetiapine than with SSRIs.

Baricitinib effectively treats severe alopecia for up to 104 weeks.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Pharmacists play a key role in managing the use of anxiety medications and ensuring patients use them correctly.

Cepharanthine and berbamine may affect SK channels, influencing their therapeutic effects.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

Baricitinib helps keep hair, eyebrows, and eyelashes regrown for 3 years in most people with severe hair loss.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

Breezula® may be more effective than Minoxidil in promoting hair growth by reducing a hair growth inhibitor.

Female rats showed more panic-related behavior than males, influenced by hormonal cycles and certain drugs.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.